Funder: National Institutes of Health (NIH)

Due Dates: February 5, 2024 (New) | March 5, 2024 (Renewal/Resubmission) | June 5, 2024 (New) | July 5, 2024 (Renewal/Resubmission) | October 5, 2024 (New) | November 5, 2024 (Renewal/Resubmission)

Funding Amounts: No set budget limit; project periods up to 5 years; budgets must reflect actual project needs.

Summary: Supports prospective clinical research to validate biomarkers and clinical outcome assessments (COAs) for clinical trial readiness in Functional Neurological Disorders (FNDs).

Key Information: Cooperative agreement mechanism with substantial NIH involvement; clinical trial optional; applications must address clinical trial readiness including biomarker and COA validation with defined context of use.